2008
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants
Görk A, Ehrenkranz R, Bracken M. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. Cochrane Database Of Systematic Reviews 2008, 2010: cd006071. PMID: 18254092, PMCID: PMC8912238, DOI: 10.1002/14651858.cd006071.pub2.Peer-Reviewed Original ResearchConceptsSymptomatic patent ductus arteriosusPatent ductus arteriosusTreatment of PDAContinuous indomethacin infusionRetinopathy of prematurityPDA closurePreterm infantsBolus administrationBolus injectionBlood flowBronchopulmonary dysplasiaIndomethacin infusionIntraventricular hemorrhagePremature infantsContinuous infusionMesenteric circulationRelative riskRisk differencePatent ductus arteriosus closureCerebral blood flow velocityAdverse effectsCochrane Neonatal reviewsContinuous infusion groupIntermittent bolus dosesSymptomatic preterm infants
1992
Plasma Thyroid Hormones and Prolactin in Premature Infants and Their Mothers after Prenatal Treatment with Thyrotropin-Releasing Hormone
Ballard P, Ballard R, Creasy R, Padbury J, Polk D, Bracken M, Moya F, Gross I. Plasma Thyroid Hormones and Prolactin in Premature Infants and Their Mothers after Prenatal Treatment with Thyrotropin-Releasing Hormone. Pediatric Research 1992, 32: 673-678. PMID: 1287557, DOI: 10.1203/00006450-199212000-00009.Peer-Reviewed Original ResearchConceptsThyroid hormonesFree thyroxineThyrotropin-releasing hormone treatmentNewborn lung diseaseDoses of TRHMU/LPituitary-thyroid functionPlasma of womenThyrotropin-Releasing HormoneWk of gestationPmol/LPlasma thyroid hormonesCord TSHTRH i.Preterm fetusesCord concentrationsControl infantsPremature infantsPostnatal surgeTRH administrationLung diseaseCord bloodPrenatal treatmentTriiodothyronine levelsHormone treatment